Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
P
M0930-03-16
Paclitaxel Nanomicelles in 2D Monolayer and 3D Multicellular Spheroid Models of Triple-Negative Breast Cancer
Favorite
W0930-06-40
PAIex: A Virtual Expert Tool for Enhanced Pre-Approval Inspection Preparedness
Favorite
M1230-03-20
Pathological and Demographic Determinants of SARS-CoV-2-mediated Dysregulation of Drug Processing Pathways
Favorite
M1330-07-44
Patient In-Use Stability of FDA-Approved Delayed-Release Products of Divalproex
Favorite
T1030-06-38
Paving the Road to Use saRNA Loaded into Polymeric Nanoparticles as Nanovaccines Platform to Target Glioblastoma
Favorite
M0930-05-30
PBPK-Based Prediction of Obesity-Mediated Changes in Small Molecule Pharmacokinetics
Favorite
T1330-06-39
Pea Starch as an Environmentally Sustainable Solution in Pharmaceutical Film Coating Applications Using the ReadiLYCOAT
®
System
Favorite
W1230-03-17
Peptide-Based Nanoplatform for Improved Cas9 RNP Delivery and Editing
Favorite
M1330-03-18
Permeability of Small Molecular Weight Compounds and Macromolecules through Ex Vivo Rabbit Ocular Tissues
Favorite
M1030-09-56
Personalized 3D-Printed Tablets for Diabetes and Related Complications: Design, Optimization, and Evaluation
Favorite
M1130-08-50
Personalized Drug Delivery via 3D-Printed Tablets: Optimizing Patient-Specific Release Kinetics Using a Central Composite Design
Favorite
W0930-05-29
Pharmacokinetic Differences of Paclitaxel and Cyclopamine in Healthy and HCC Mice when Co-administered via Polymeric Micelle and Cremophor EL
Favorite
T1030-08-48
Pharmacokinetic Modulation of PLD1 Inhibitor via Exosome Delivery: Enhanced Brain Retention for Alzheimer’s Disease Treatment
Favorite
T0930-07-47
Pharmacokinetic Study of the Effect of Buffer on Long-Acting Injectable Formulations
Favorite
W1230-03-19
Pharmacokinetics and Biodistribution of FVIII Containing LysoPS Nanoparticle Following IV Administration
Favorite
M1130-05-33
Physicochemical and Biopharmaceutical Characterization of Locally Bioavailable COX-2 Inhibitor for Familial Adenomatous Polyposis
Favorite
M1230-05-31
Physiologically Based Biopharmaceutics Modeling of Formulation Bioequivalence for Mobocertinib, a Weak Base, Using pH-Dependent Dissolution Data
Favorite
T1430-05-27
Physiologically Based Pharmacokinetic Modeling to Inform Lenacapavir Dose Regimen when Co-Administered with Rifamycins in Participants with Tuberculosis
Favorite
T1230-09-61
Physiologically Based Pharmacokinetic Simulations Using Transdermal Compartmental Absorption and Transit Model (TCAT) for RLS-1496 Dermal Preparations
Favorite
M1530-05-28
Piperazine Based Lipid Nanoparticles Facilitate Enhanced Endosomal Escape and CRISPR-Cas9 Mediated HIV-1 Proviral DNA Excision
Favorite
M1330-01-03
Plasma and Gastrointestinal Tissue Analysis of Prednisolone in Mice Following LPS-Induced Inflammation
Favorite
T0930-09-60
Poloxamers in Continuous Melt Granulation: Dual Role as a Binder and a Solubilizer
Favorite
T0930-08-50
Polymer Coated Solid Injectable Dispersions for Long-Acting Delivery of Tenofovir Alafenamide
Favorite
T1330-07-42
Polymer-Based Implant for the Sustained, Controlled Release of Antisense Oligonucleotides for the Treatment of Chronic Conditions
Favorite
M1030-08-49
Polymers as the Stabilizing Excipient for Spray-Dried Solid-State Protein Formulations
Favorite
W1230-06-38
Polysorbate Hydrolysis and Protein Stability: Investigating the Role of Free Fatty Acid Particles
Favorite
T0930-09-59
Population Balance Modeling of Aggregation in Long-Acting Injectable Formulations Integrated with PBPK
Favorite
T1030-05-29
Population Pharmacokinetic Modeling of Rezpegaldesleukin after Subcutaneous Dosing to Account for Variability Across Multiple Patient Populations with Autoimmune Diseases
Favorite
M1230-08-52
Potential of Ultra Fine Bubbles to Enhance Insulin Membrane Permeability
Favorite
M1130-02-09
Powder Rheology for Batch Comparison During Manufacturing
Favorite
M1530-02-12
Powder-Discharge KinetiSol® Process Produces Nano- and Micron-Sized Particle Aggregates for Drug Delivery
Favorite
W1230-08-50
Preclinical Development of a Long-Acting Injectable Formulation of Rifapentine from High Throughput Screening through to a GLP-Toxicology Study
Favorite
M1430-09-61
Preclinical Development of Long-Acting Injectable Formulations of Glecaprevir and Pibrentasvir for Curative Treatment of Hepatitis C in Low- and Middle-Income Countries
Favorite
M1330-05-29
Predicting Aflibercept Local Exposure in Humans Using an Ocular PBPK Model
Favorite
M1030-06-37
Predicting Drug Release from EVA-Based Long-Acting Implants: Mechanisms, Modeling, and Simulation of Drug Release
Favorite
M1230-08-50
Predicting Lung Dose and Asthma Control from Real-World Dry Powder Inhaler Use
Favorite
M1230-09-60
Predicting the Stability of Lyophilized Formulations Containing a Monoclonal Antibody and Sucrose/Trehalose Using Solid-State NMR Spectroscopy
Favorite
M1530-07-47
Predicting the Tabletability of Powder Mixtures Lubricated with Magnesium Stearate
Favorite
T1330-03-15
Prediction of DNA-Targeting Anti-Cancer Therapeutics Using Machine Learning-Guided Molecular Docking
Favorite
M1430-05-32
Prediction of Human Volume of Distribution Using Animal PBPK Modeling and Simulation with Octanol-Water Partition Coefficient or Tissue-to-Plasma Partition Coefficient Scaling
Favorite
M0930-07-45
Predictive Stability Modeling of Softgels
Favorite
T1330-01-04
Pre-Formulation Characterization and Stability Evaluation of a Novel Peptide-Based Drug for Triple-Negative Breast Cancer Treatment
Favorite
T1530-08-49
Preparation and Characterization of Cocrystals and Salts of an Indole-2-Carboxamide Anti-Mycobacterial Agent
Favorite
M1430-08-49
Preparation, Characterization, and Evaluation of Cellular Uptake of Spray-Dried Albumin Nanoparticles
Favorite
M1130-07-42
Prevention of Lung Cancer Using Bio-Enhanced Sulfasalazine and Disulfiram Nano Self-Emulsifying Drug Delivery System Platform: Formulation Development, Pharmacokinetics, and Biodistribution Study
Favorite
T1430-07-47
Probing Dynamics of Amorphous Solid Dispersions Using Carboxylic Acid Dimer Formation
Favorite
M1230-02-10
Probing Product Quality of Lyophilized Formulations Via Solid-State Nuclear Magnetic Resonance Spectroscopy
Favorite
M1430-09-55
Process Change in Cell Culture Significantly Improves Aggregates in Drug Product
Favorite
W1230-07-44
Process Optimization for Benzoic Acid Spherical Agglomeration: Bridging Liquid Solubility and Supersaturation of Primary Crystallization
Favorite
M1330-09-55
Process Optimization of Preparing Lysozyme-Loaded Liposomal Dry Powder via Design of Experiments
Favorite
T1230-02-12
Producing ASDs with Pressure Nozzles Using Laboratory Scale Spray Dryers
Favorite
M1230-07-47
Programmable Delayed-Release Container System (PDRCS) for Chronopharmaceutical Drug Delivery: Application to Addison’s Disease
Favorite
M1030-02-13
Protein-Surfactant Interactions at Solid-Liquid Interfaces of Diverse Primary Packaging Materials for Biopharmaceuticals
Favorite
W0930-06-36
Pulmonary Delivery of Drug-Loaded Superparamagnetic Iron Oxide Nanoparticles for Diagnosis and Treatment of Tuberculosis
Favorite
